Skip to main content

Navigation group

Type at least 3 characters
2,249 articles

Articles

Original Research

Published on 11 Jul 2023

Expression of SRP-9001 dystrophin and stabilization of motor function up to 2 years post-treatment with delandistrogene moxeparvovec gene therapy in individuals with Duchenne muscular dystrophy

in Molecular and Cellular Pathology

  • Jerry R. Mendell
  • Perry B. Shieh
  • Craig M. McDonald
  • Zarife Sahenk
  • Kelly J. Lehman
  • Linda P. Lowes
  • Natalie F. Reash
  • Megan A. Iammarino
  • Lindsay N. Alfano
  • Brenna Sabo
Expression of SRP-9001 dystrophin and stabilization of motor function up to 2 years post-treatment with delandistrogene moxeparvovec gene therapy in individuals with Duchenne muscular dystrophy
Frontiers in Cell and Developmental Biology
doi 10.3389/fcell.2023.1167762
  • 17,217 views
  • 27 citations